Imexpharm Corporation

VND 35,000As of Sun 8 Nov 2026, 12:00 UTC
HOSE:IMPHealthcare
Country Vietnam
PE (Fwd) •••
TSR 10Y CAGR 10.29%
Div yield 1.43%
ROE 15.89%
Pharmaceutical Preparations
Beta (5Y) 0.42
PE TTM 16.81
TSR TTM (29.11%)
Mkt cap VND 5.390T
ROIC 17.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
VND 42,984
22.81%
(89.89%)
Hold 5|9|6|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareVND
418.66
461.42
511.68
529.44
(6.18%)
(1.64%)
14.67%
23.92%
RevenueVND B
572.9
573.3
587.2
588.3
6.93%
5.41%
2.22%
1.43%
Peers (US$209.9M)
Cap (US$)
PE
110.9M
9.556x
Capital
TTM
5Y
10Y
Leveragex
0.075
4.220
3.156
EBIT/Intx
0.110
2.501
2.770
Own earn%
66.81
(23.93)
(1.02)
Sh yield%
23.40
61.72
61.25
Owners
Insiders/Inst%
6.37
33.92
Short interest%
1.21
SBC / revenue%
5.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
9–13
$1 testx
—
Incr. ROIC%
0